VIGLIAR, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 1.769
EU - Europa 780
AS - Asia 504
AF - Africa 36
OC - Oceania 2
Totale 3.091
Nazione #
US - Stati Uniti d'America 1.744
IT - Italia 509
SG - Singapore 323
CN - Cina 149
NL - Olanda 70
FI - Finlandia 46
IE - Irlanda 46
DE - Germania 40
CI - Costa d'Avorio 35
CA - Canada 22
GB - Regno Unito 22
IN - India 18
ES - Italia 12
FR - Francia 12
VN - Vietnam 5
RS - Serbia 4
SE - Svezia 4
MX - Messico 3
PK - Pakistan 3
RO - Romania 3
AU - Australia 2
BE - Belgio 2
HK - Hong Kong 2
HR - Croazia 2
LT - Lituania 2
UA - Ucraina 2
AT - Austria 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ID - Indonesia 1
IR - Iran 1
JP - Giappone 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 3.091
Città #
Chandler 395
Singapore 278
Naples 119
Millbury 112
Ashburn 95
Santa Clara 80
Napoli 77
Amsterdam 67
Des Moines 60
Lawrence 59
Wilmington 40
Boston 38
Princeton 38
Beijing 37
Nanjing 33
Milan 21
Ottawa 20
Munich 16
Nanchang 14
Rome 12
Valencia 11
Falls Church 10
Redwood City 10
Shenyang 10
Fairfield 9
Hebei 9
Helsinki 9
Portici 9
Salerno 9
Jiaxing 8
Dublin 7
Pune 7
Santa Maria 7
Seattle 7
Woodbridge 7
Caserta 6
Guangzhou 6
Viareggio 6
Dallas 5
Lappeenranta 5
Pagani 5
Washington 5
Belgrade 4
Chieti 4
Dong Ket 4
Houston 4
Marigliano 4
Pomigliano d'Arco 4
Bologna 3
Cava 3
Changsha 3
Edinburgh 3
Formia 3
Frankfurt am Main 3
Giugliano in Campania 3
Grosseto 3
Hanover 3
Karachi 3
London 3
Messina 3
Norwalk 3
Ronco all'Adige 3
Salt Lake City 3
Alba 2
Bagnoli Irpino 2
Brindisi 2
Brussels 2
Cava De' Tirreni 2
Cava de' Tirreni 2
Cernobbio 2
Coyoacán 2
Farindola 2
Fremont 2
Gragnano 2
Hangzhou 2
Hong Kong 2
Indiana 2
Karlsruhe 2
Kronberg 2
Lucca 2
Marano Di Napoli 2
Marano di Napoli 2
Melito Di Napoli 2
Monza 2
Paris 2
Pietrasanta 2
Reggio Calabria 2
Rivoli 2
Scafati 2
Shanghai 2
Stockholm 2
Tianjin 2
Andrano 1
Angera 1
Angri 1
Aurora 1
Avellino 1
Bari 1
Bloomfield 1
Bollate 1
Totale 1.913
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 97
2-deoxy-2[F-18] fluoro-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma 65
Metabolic flexibility in melanoma: A potential therapeutic target 57
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 53
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 51
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 51
Correspondence in reference to the previously published Epub manuscript by Peter Hokland et al. 'How I treat advanced Hodgkin lymphoma - a global view'. Br J Haematol. 2020;190:837-50 46
Antitumor efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models. 45
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 45
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 45
CD10 is useful to identify gastrointestinal contamination in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) cytology from pancreatic ductal adenocarcinoma. 44
Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation 44
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study 43
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations. 43
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 43
Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better?. 42
Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective 42
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 42
Cytopathologists can reliably perform ultrasound-guided thyroid fine needle aspiration: a 1-year audit on 3715 consecutive cases 41
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 41
KRAS Mutant Allele Specific Imbalance (MASI) assessment in routine samples of metastatic colorectal cancer patients 40
Inflammatory myofibroblastic bladder tumor in a patient with wolf-hirschhorn syndrome 40
Role of Cytomorphology in the Era of Liquid Biopsy 40
The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience 39
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 39
Breast implant associated anaplastic large cell lymphoma (BIA-ALCL): a challenging cytological diagnosis with hybrid PET/MRI staging and follow-up 39
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 38
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients 37
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 36
Microfluidic chip technology applied to fine-needle aspiration cytology samples for IGH clonality assessment 36
Coexistence of Primary Gastric Giant Cell-Rich Leiomyosarcoma and Gastrointestinal Stromal Tumor: Report of a Very Rare Case and Review of the Literature. 35
Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens 35
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 35
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 35
Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients 34
Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study 34
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 34
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 33
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 33
Brca1/2 ngs somatic testing in clinical practice: a short report 33
Gastric duplication cyst: a rare congenital disease often misdiagnosed in adults. 32
Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR 32
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 32
How should a follicular adenoma with papillary architecture be classified on thyroid FNA? Case report with histological correlation 31
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx 31
Methods for actionable gene fusion detection in lung cancer: now and in the future 31
Fine-needle aspiration findings in focal (nodular) myositis of a newborn: A case report 30
Lung adenocarcinoma and its thyroid metastasis characterized on fine-needle aspirates by cytomorphology, immunocytochemistry, and next-generation sequencing 30
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens 30
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 30
Cytology in the time of coronavirus disease (covid-19): An Italian perspective 30
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 30
Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer 29
Predictive molecular pathology in the time of COVID-19 29
Biomarkers predictive value in early stage non-small cell lung cancer 29
Morphological and immunocytochemical features of Merkel cell carcinoma metastatic to the pancreas diagnosed by endoscopic ultrasound-guided fine-needle aspiration 28
Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better? 27
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 27
Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples? 27
Non lymphomatous clonal B-Cell populations in enlarged lymph nodes in acquired immunodeficiency syndrome 27
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 27
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 27
Next generation sequencing in cytology 26
PD-L1 and beyond: Immuno-oncology in cytopathology 26
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 25
Lymph nodes fine needle cytology in the diagnosis of infectious diseases: clinical settings 25
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 25
Cytopathology meets basic science 24
Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload 24
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 23
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 23
Epidermal Growth Factor Receptor Test Performed on Liquid-Based Cytology Lung Samples: Experience of an Academic Referral Center. 22
Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience 22
Digital Examination of LYmph node CYtopathology Using the Sydney system (DELYCYUS). An international, multi-institutional study 21
CYTOLOGICAL APPROACH TO THE DIAGNOSIS OF LYMPHOPROLIFERATIVE PROCESSES OF THE ORAL CAVITY 21
Outsourcing cytological samples to a referral laboratory for EGFR testing in non-small cell lung cancer: does theory meet practice? 21
How to prepare cytological samples for molecular testing 21
Early cytological diagnosis of extranodal stage I, primary thyroid Non-Hodgkin lymphoma in elderly patients. Report of two cases and review of the literature 21
A novel approach to classification and reporting of lymph node fine-needle cytology: Application of the proposed sydney system 21
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice 21
Sulfur Exafluoride Contrast-Enhanced Ultrasound Showing Early Wash-Out of Marked Degree Identifies Lymphoma Invasion of Spleen with Excellent Diagnostic Accuracy: A Monocentric Study of 260 Splenic Nodules 21
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 20
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries 20
Fine needle cytology, infectious diseases and non-Hodgkin lymphoma 19
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 19
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 19
A narrative review of predictive immuno-histo/cyto chemistry in lung cancer: focus on gene fusions and PD-L1 expression 18
Intra-institutional second opinion diagnosis can reduce unnecessary surgery for indeterminate thyroid FNA: A preliminary report on 34 cases 18
Multiple metachronus proliferative fasciitis occurring in different anatomic regions: A case report and review of the literature 18
Molecular predictive testing in precision oncology: The Italian experience 18
Juggling the COVID-19 pandemic: A cytopathology point of view 18
Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21 17
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 17
Relevance of the College of American Pathologists’ Guideline for Validating Whole Slide Imaging for Diagnostic Purposes to Cytopathology 17
Lymph node fine needle cytology in the staging and follow-up of cutaneous lymphomas. 17
Lymph node and lymphoid organs fine needle aspiration cytology: historical background. 17
Evaluation of KRAS, NRAS and BRAF mutational status and microsatellite instability in early colorectal carcinomas invading the submucosa (pT1): Towards an in-house molecular prognostication for pathologists? 17
Fine needle aspiration cytology of a cutaneous metastasis from an extraadrenal paraganglioma: a case report. 16
Fine-needle cytology and flow cytometry assessment of reactive and lymphoproliferative processes of the breast. 15
Histological and fine needle aspiration cytological features of Hashimoto thyroditis-associated ?angiomatoid? papillary thyroid carcinoma 15
Totale 3.119
Categoria #
all - tutte 18.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020125 0 0 0 0 0 7 1 58 0 18 34 7
2020/2021178 7 2 5 4 16 39 9 28 37 21 2 8
2021/2022600 13 12 12 14 12 15 6 34 55 58 145 224
2022/2023944 106 66 34 66 129 115 7 110 170 74 50 17
2023/2024606 33 114 60 40 21 36 7 86 26 23 88 72
2024/2025502 166 193 4 36 102 1 0 0 0 0 0 0
Totale 3.322